Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

Presentation TCT 2020

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

Presenter: George Vlachojannis

October 14, 2020

Presentation TCT Abstracts Posters 2018

A comparative study of one year all-cause mortality in ST Elevation myocardial infarction patients treated with prasugrel and ticagrelor after primary percutaneous coronary intervention

Presenter: Ayush Khurana

September 25, 2018

Presentation AHA 2017

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Presenter: Zuzana Motovska

November 11, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

Presentation EuroPCR 2017

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

Presenter: Mamas A. Mamas

May 22, 2017

Presentation ESC 2016

PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI

Presenter: Zuzana Motovska

August 30, 2016

Presentation

CRUSH: Crushed Prasugrel Tablets in STEMI Patients Undergoing Primary PCI

Presenter: Fabiana Rollini

March 28, 2016

Presentation

RECLOSE-3: Prasugrel in Clopidogrel Nonresponders Undergoing PCI

Presenter: R. Valenti

September 17, 2015

Presentation

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Presenter: P. Widimsky

June 19, 2015

Presentation

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Presenter: Jose Carlos Nicolau

June 17, 2015

Presentation

Comparison of Ticagrelor vs Prasugrel to Prevent Periprocedural Myonecrosis in ACS

Presenter: Laurent Bonello

June 03, 2015

Presentation

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Presenter: Usman Baber

May 11, 2015

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation ESC 2014

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

Presenter: Petr Widimsky

September 02, 2014

Presentation

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Presenter: Akshay Bagai

August 12, 2014

Presentation

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Presenter: J.A. Udell

June 17, 2014

Presentation

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Presenter: Stefanie Schulz

May 14, 2014

Presentation

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

Presenter: Dimitrios Alexopoulos

April 09, 2014

Presentation

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Presenter: Sorin J. Brener

February 26, 2014

Presentation TCT 2013

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Presenter: Michel Le May

October 30, 2013

Advertisement

Effect of pre-hospital crushed prasugrel tablets in patients with STEMI planned for primary percutaneous coronary intervention: The COMPARE CRUSH Trial

A comparative study of one year all-cause mortality in ST Elevation myocardial infarction patients treated with prasugrel and ticagrelor after primary percutaneous coronary intervention

One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Prasugrel, Ticagrelor and Clopidogrel in PPCI for STEMI: An Analysis of Comparative Clinical Outcomes from the UK BCIS National Registry

PRAGUE-18 Study: Randomized Comparison Of Ticagrelor Versus Prasugrel In STEMI

CRUSH: Crushed Prasugrel Tablets in STEMI Patients Undergoing Primary PCI

RECLOSE-3: Prasugrel in Clopidogrel Nonresponders Undergoing PCI

Predictors of Bleeding in ACS Patients Treated With Prasugrel

Concomitant PPI Use, Platelet Activity, and Clinical Outcomes in ACS Patients Treated With Prasugrel vs Clopidogrel and Managed Without Revascularization

Comparison of Ticagrelor vs Prasugrel to Prevent Periprocedural Myonecrosis in ACS

PROMETHEUS: Clinical Assessment of ACS Patients Managed With PCI and Treated With Prasugrel or Clopidogrel

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

In-Hospital Switching Between Clopidogrel and Prasugrel Among Patients with AMI Treated with PCI

Prasugrel vs Clopidogrel in STEMI Patients According to Timing of PCI

Prasugrel plus Bivalirudin vs Clopidogrel plus Heparin in Patients with STEMI

Onset of Antiplatelet Action with High (100 mg) vs Standard (60 mg) Loading Dose of Prasugrel in STEMI Patients Undergoing Primary PCI

INFUSE-AMI: Outcomes in Patients with STEMI Treated with Clopidogrel vs Prasugrel

Pre-load wtih Platelet ADP Receptor Inhibition in STEMI: Prasugrel, Ticagrelor, Clopidogrel, Or Does it Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content